Delivery Order SPE2DB24D2003-SPE2DB24FXEF8
Award Date
5/6/24
Potential Completion Date
5/7/24
Potential Value
$8.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract worth $1,889.10 to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the provision of GARDASIL 9 SYRINGE 0.5ML, a pharmaceutical product. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of...
The U.S. Defense Logistics Agency (DLA) awarded a $4,838.46 Firm Fixed Price Delivery Order contract to Amerisourcebergen Drug Corp's Corporate Office Division to provide GARDASIL 9 SYRINGE 0.5ML. This delivery order falls under a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to...
The Defense Logistics Agency (DLA) awarded a $5,250.63 firm-fixed-price delivery order to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of GARDASIL 9 SYRINGE 0.5ML. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with Amerisourcebergen valued at up to $999,999,999.00, which runs through November 2026. The IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical...
The U.S. Defense Logistics Agency (DLA) awarded a $32,103.85 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp's Corporate Office division for the supply of 4,565,218,430 units of the GARDASIL 9 vaccine syringe (0.5 mL). This delivery order falls under AmerisourceBergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through December 2025. The contract has no set-aside designation and is for the delivery of critical...
The U.S. Defense Logistics Agency (DLA) awarded a $9,366.31 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of GARDASIL 9 syringes. This delivery order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded by DLA to Amerisourcebergen Drug Corp to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA Troop Support Medical...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $102,501.72 to Amerisourcebergen Drug Corp, the prime contractor, to provide GARDASIL 9 vaccine syringes. This order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded by DLA to Amerisourcebergen Drug Corp, which serves as the primary vehicle for the company to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical...
The Defense Logistics Agency (DLA) awarded a delivery order contract valued at $7,613.41 to AmerisourceBergen Drug Corp's Corporate Office Division for the supply of GARDASIL 9 vaccine syringes. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that AmerisourceBergen holds with DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to...
The U.S. government's Defense Logistics Agency (DLA) Troop Support Medical awarded a delivery order worth $9,535.20 to AmerisourceBergen Drug Corporation's Corporate Office Division. The order is for the supply of GARDASIL 9, a 0.5 ml syringe vaccine, with a period of performance through September 6, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 that AmerisourceBergen holds with DLA Troop Support Medical for providing a comprehensive...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $6,528.44 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of GARDASIL 9 vaccine syringes. This delivery order is part of a larger indefinite delivery contract (IDC) valued up to $999,999,999.00 awarded to AmerisourceBergen Drug Corp as the sole prime contractor, which serves as the primary vehicle for the company to provide a range of pharmaceutical...
The U.S. government's Defense Logistics Agency (DLA) Troop Support Medical awarded a $3,233.58 firm fixed price delivery order contract (SPE2DX15D3008|SPE2DX24F11HV) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of GARDASIL 9 SYRINGE 0.5ML. This delivery order is part of a broader indefinite delivery contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen Drug Corp holds with DLA to deliver pharmaceutical products and medical supplies...